Evaluation of a rapid antigen detection test (Panbio™ COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a pediatric emergency department.

We evaluated the Panbio™ COVID-19 Ag Rapid Test Device as a point-of-care diagnostic tool for COVID-19 in 357 patients at a pediatric emergency department. Thirty-four patients tested positive by reverse transcription polymerase chain reaction, of which 24 were positive by the antigen assay. The sen...

Descripción completa

Detalles Bibliográficos
Autores: Carbonell-Sahuquillo, S, Lazaro-Carreno, MI, Camacho, J, Barres-Fernandez, A, Albert, E, Torres, I, Breton-Martinez, JR, Martinez-Costa, C, Navarro, D
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:INCLIVA
Repositorio:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
OAI Identifier:oai:incliva.fundanetsuite.com:p15869
Acceso en línea:https://incliva.portalinvestigacion.com/publicaciones/15869
Access Level:acceso abierto
Palabra clave:SARS-CoV-2 RNA viral load
clinical sensitivity
emergency department
field evaluation
pediatric patients
rapid antigen assay
Descripción
Sumario:We evaluated the Panbio™ COVID-19 Ag Rapid Test Device as a point-of-care diagnostic tool for COVID-19 in 357 patients at a pediatric emergency department. Thirty-four patients tested positive by reverse transcription polymerase chain reaction, of which 24 were positive by the antigen assay. The sensitivity and specificity of the assay were 70.5% and 100%, respectively.